Standardize & Scale Biomarker Operations Across Increasingly Complex Trials to Prevent Critical Delays & Keep Studies On Track
For the very first time, the biomarker and biospecimen management community will have a forum solely dedicated to this rapidly expanding and ever-increasingly critical function.
As trials expand globally and become more sample-intensive, protecting sample integrity and turning specimen data into trustworthy decisions has never mattered more. The inaugural Biomarker Operations & Biospecimen Management Summit provides a long-overdue home to share experiences and define the standards this field now demands.
Following the complete sample lifecycle, from kit design and site collection, through to tracking, storage, biobanking, lab coordination and data harmonization, walk away with the real-time insights needed to implement robust, scalable biomarker and biospecimen operations.
Join 80+ fellow senior leaders from biopharma, labs, CROs, and biobanks, in the united mission of ensuring every sample is treated with the precision, rigor and care it requires.
Biomarker operations may work behind the scenes, but every breakthrough begins with and relies on getting the right samples
Head, Oncology Translational Medicine Operations & Experimental Oncology, AstraZeneca, 2026 Speaker
I’m excited to be part of this inaugural summit and look forward to collaborating with industry leaders who are passionate about driving innovation, collaboration and operational excellence across the biospecimen management ecosystem
Executive Director & Head, Consent, Biospecimens & Imaging, Bristol Myers Squibb, 2026 Speaker
The Biospecimen Management Consortium was founded on the belief that the biggest challenges in biospecimen management cannot be solved by any one stakeholder alone. I'm excited to continue that conversation with leaders from across the clinical trial ecosystem and explore how collaboration can help move us forward
Founder, Biospecimen Management Consortium (BMC), 2026 Speaker
Delve into the Full Program to Discover
- Perspectives from 27+ Expert Speakers from Leading Pharma, Biotech & Consortia Organizations
- Real-World Insights from 20+ Case Studies Spanning the Full Sample Lifecycle
- Dedicated Networking Opportunities Built to Strengthen & Spark Collaborations
- The Complete Session, Panel & Roundtable Details Hyper-Relevant to Every Stakeholder
- The Industry's First & Only Dedicated Forum to the Biomarker Operations & Biospecimen Management Community
Official Partners
Biopharma Companies Attending
About the World Biomarkers & Diagnostics Event Series
The inaugural Biomarker Operations & Biospecimen Management Summit sits within the wider World Biomarkers & Diagnostics Event Series, which serves as the trusted home of the global precision medicine community.
We pride ourselves on convening senior stakeholders from biopharma, diagnostics, technology, testing laboratories, and healthcare organizations to accelerate the next wave of biomarker and diagnostic-driven therapies to market.
Our audience are united in the shared goal that biomarkers and diagnostics are fundamental to the future of precision medicine. As testing becomes increasingly critical to identifying the right patients and enabling more effective therapies, our mission remains simple; to ensure the right treatment reaches the right patient, at the right time.
Discover the New Agenda
Hear the latest breakthroughs in biomarker operations and gain exclusive insights across industry-led sessions, interactive BMC roundtables, and discussion-based panels
Partner With the Future
Position your organization directly alongside the architects of modern biomarker operations to ensure your brand is at the heart of every sample lifecycle decision
Join Biomarker Stakeholders
Be part of the first forum dedicated to this space, connecting with senior decision-makers from biopharma, central labs, and diagnostics across two action-packed conference days